Acute Myeloid Leukemia Global Market Report 2022

Jun 2022| TBR2229A| TBRC (Publisher)

Report Highlights

Including: 1) By Treatment Type: Chemotherapy; Radiation therapy; Stem Cell Transplant; Targeted Therapy
2) By Chemotherapy: Cytarabine; Anthracycline Drugs; Alkylating Agents; Anti-metabolites; Tyrosine Kinase Inhibitors; Hormonal Therapy
3) By Regimen: DC Regimen; AVD Regimen; VCD Regimen
4) By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; Clinics
Covering: Pfizer Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation); Bristol Myers Squibb ; Amgen Inc.

Acute Myeloid Leukemia Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global acute myeloid leukemia market.

This report focuses on acute myeloid leukemia market which is experiencing strong growth. The report gives a guide to the acute myeloid leukemia market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the acute myeloid leukemia? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Acute Myeloid Leukemia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider acute myeloid leukemia market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The acute myeloid leukemia market section of the report gives context. It compares the acute myeloid leukemia market with other segments of the acute myeloid leukemia market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, acute myeloid leukemia indicators comparison.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Treatment Type: Chemotherapy; Radiation therapy; Stem Cell Transplant; Targeted Therapy
  • By Chemotherapy: Cytarabine; Anthracycline Drugs; Alkylating Agents; Anti-metabolites; Tyrosine Kinase Inhibitors; Hormonal Therapy
  • By Regimen: DC Regimen; AVD Regimen; VCD Regimen
  • By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; Clinics

Companies Mentioned: Pfizer Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation); Bristol Myers Squibb ; Amgen Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3 : Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4 : Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5 : Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6 : Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : China, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : China, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13 : India, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14 : India, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15 : Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16 : Japan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17 : Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18 : Australia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19 : Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20 : Indonesia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21 : South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22 : South Korea, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23 : Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24 : Western Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25 : UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26 : UK, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27 : Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 28 : Germany, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 29 : France, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 30 : France, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 31 : Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 32 : Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 33 : Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 34 : Russia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 35 : North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 36 : North America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 37 : USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 38 : USA, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 39 : South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 40 : South America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 41 : Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 42 : Brazil, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 43 : Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 44 : Middle East, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 45 : Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 46 : Africa, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 47 : Pfizer Inc. Financial Performance
  • Table 48 : Novartis AG Financial Performance
  • Table 49 : Sanofi-Aventis (Genzyme Corporation) Financial Performance
  • Table 50 : Bristol Myers Squibb Financial Performance
  • Table 51 : Amgen Inc. Financial Performance
  • Figure 1 : Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3 : Global Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4 : Global Acute Myeloid Leukemia Market, Segmentation By Chemotherapy, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5 : Global Acute Myeloid Leukemia Market, Segmentation By Regimen, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6 : Global Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Acute Myeloid Leukemia Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Global Acute Myeloid Leukemia Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : Asia-Pacific, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : China, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : China, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13 : India, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14 : India, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15 : Japan, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16 : Japan, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17 : Australia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18 : Australia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19 : Indonesia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20 : Indonesia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21 : South Korea, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22 : South Korea, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23 : Western Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24 : Western Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25 : UK, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26 : UK, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27 : Germany, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 28 : Germany, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 29 : France, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 30 : France, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 31 : Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 32 : Eastern Europe, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 33 : Russia, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 34 : Russia, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 35 : North America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 36 : North America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 37 : USA, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 38 : USA, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 39 : South America, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 40 : South America, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 41 : Brazil, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 42 : Brazil, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 43 : Middle East, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 44 : Middle East, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 45 : Africa, Acute Myeloid Leukemia Market, Segmentation By Treatment Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 46 : Africa, Acute Myeloid Leukemia Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 47 : Pfizer Inc. Financial Performance
  • Figure 48 : Novartis AG Financial Performance
  • Figure 49 : Sanofi-Aventis (Genzyme Corporation) Financial Performance
  • Figure 50 : Bristol Myers Squibb Financial Performance
  • Figure 51 : Amgen Inc. Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.